Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism (Q28593406)

2

1 reference

31 January 2017

A. Hoffmann

3

1 reference

31 January 2017

Y. Okuda

4

1 reference

31 January 2017

A. Grinberg

5

1 reference

31 January 2017

H. Westphal

6

1 reference

31 January 2017

M. P. McDonald

7

1 reference

31 January 2017

J. N. Crawley

8

1 reference

31 January 2017

K. Sandhoff

9

1 reference

31 January 2017

K. Suzuki

10

1 reference

31 January 2017

R. L. Proia

https://api.crossref.org/works/10.1111/J.1460-9568.2004.03554.X

11

3

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

31 January 2017

1 reference

https://scigraph.springernature.com/pub.10.1038/ng1095-170

21 April 2017

31 January 2017

volume

11

1 reference

31 January 2017

2

5

0 references

page(s)

170–176

1 reference

31 January 2017

0 references

cites work

Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system

1 reference

https://api.crossref.org/works/10.1038/NG1095-170

Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

The Biochemistry of Sphingolipid Storage Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

Over-expression of a functionally active human GM2-activator protein in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Altering the genome by homologous recombination

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Enzyme alterations and lipid storage in three variants of Tay-Sachs disease

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Neuropathology of late onset gangliosidoses. A review

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Activating Proteins for Ganglioside GM2Degradation by β-Hexosaminidase Isoenzymes in Tissue Extracts from Different Species

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

A particle-bound sialyl lactosidoceramide splitting mammalian sialidase

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Gm2-gangliosidosis with total hexosaminidase deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

Biochemical Basis of Late-Onset Neurolipidoses

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021

A simple and novel method for tritium labeling of gangliosides and other sphingolipids

1 reference

https://api.crossref.org/works/10.1038%2FNG1095-170

7 January 2021